306 research outputs found
Clinical significance of erythromycin-resistant Campylobacter jejuni in children
Campylobacter has been recognized as the common cause of bacterial gastroenteritis in many countries. Increasing erythromycin resistance in Campylobacter jejuni infection is noted recently, but severe case was rarely reported. In this study, we aimed to clarify the clinical significance of the resistant strain of C jejuni in children. We reviewed the charts of children who were diagnosed with C jejuni enteritis in our hospital from January 2000 to December 2005, including 326 patients (117 males and 209 females). All the cases had positive stool culture. We divided them into two groups, the sensitive group (a total of 306 cases) and resistant group (a total of 20 cases), according to the drug sensitivity. We analyzed the clinical manifestations and laboratory data between the two groups. The mean age was 3.79±3.24 years in the sensitive group and 3.03±2.84 years in the resistant group. There was no significant difference between the two groups in clinical presentations and laboratory examinations. No mortality was found, and one case was initially presented with colonic perforation. This report demonstrates that infection by erythromycin-resistant strains of C jejuni has no clinical significance in children, despite the probably increased emergence of erythromycin resistance
Caffeic Acid Derivatives Inhibit the Growth of Colon Cancer: Involvement of the PI3-K/Akt and AMPK Signaling Pathways
The aberrant regulation of phosphatidylinositide 3-kinases (PI3-K)/Akt, AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (m-TOR) signaling pathways in cancer has prompted significant interest in the suppression of these pathways to treat cancer. Caffeic acid (CA) has been reported to possess important anti-inflammatory actions. However, the molecular mechanisms by which CA derivatives including caffeic acid phenethyl ester (CAPE) and caffeic acid phenylpropyl ester (CAPPE), exert inhibitory effects on the proliferation of human colorectal cancer (CRC) cells have yet to be elucidated
A cytoplasmic RNA virus generates functional viral small RNAs and regulates viral IRES activity in mammalian cells
The roles of virus-derived small RNAs (vsRNAs) have been studied in plants and insects. However, the generation and function of small RNAs from cytoplasmic RNA viruses in mammalian cells remain unexplored. This study describes four vsRNAs that were detected in enterovirus 71-infected cells using next-generation sequencing and northern blots. Viral infection produced substantial levels (\u3e105 copy numbers per cell) of vsRNA1, one of the four vsRNAs. We also demonstrated that Dicer is involved in vsRNA1 generation in infected cells. vsRNA1 overexpression inhibited viral translation and internal ribosomal entry site (IRES) activity in infected cells. Conversely, blocking vsRNA1 enhanced viral yield and viral protein synthesis. We also present evidence that vsRNA1 targets stem-loop II of the viral 5′ untranslated region and inhibits the activity of the IRES through this sequence-specific targeting. Our study demonstrates the ability of a cytoplasmic RNA virus to generate functional vsRNA in mammalian cells. In addition, we also demonstrate a potential novel mechanism for a positive-stranded RNA virus to regulate viral translation: generating a vsRNA that targets the IRES
Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer
<p>Abstract</p> <p>Background</p> <p>Patients with advanced or metastatic non-small cell lung cancer (NSCLC) can develop acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (TKIs) erlotinib and gefitinib. Here, we report the successful treatment with alternating chemotherapy and TKIs of two cases of advanced NSCLC who developed resistance to TKI.</p> <p>Case presentation</p> <p>Two patients with advanced or metastatic NSCLC were treated with palliative chemotherapy followed by erlotinib/gefitinib. When TKI therapy failed, two cycles of chemotherapy were provided, which were followed by re-challenge with erlotinib or gefitinib.</p> <p>Conclusion</p> <p>NSCLC patients with acquired TKI resistance should be managed aggressively whenever possible. Subsequent chemotherapy and target treatment is one of the reasonable choices for those with an initial dramatic clinical response with erlotinib/gefitinib treatment. Further studies are warranted to substantiate the association of erlotinib /gefitinib treatment with the efficacy of NSCLC patients with acquired TKI failure.</p
The Greenland Telescope: Construction, Commissioning, and Operations in Pituffik
In 2018, the Greenland Telescope (GLT) started scientific observation in
Greenland. Since then, we have completed several significant improvements and
added new capabilities to the telescope system. This paper presents a full
review of the GLT system, a summary of our observation activities since 2018,
the lessons learned from the operations in the Arctic regions, and the prospect
of the telescope.Comment: 26 pages, 11 figures, and 8 tables. This is the version of the
article before publication editing, as submitted by an author to Publications
of the Astronomical Society of the Pacific. IOP Publishing Ltd is not
responsible for any errors or omissions in this version of the manuscript or
any version derived from it. The Version of Record will be added when it
becomes availabl
Tests of AMiBA Data Integrity
We describe methods used to validate data from the Y.T. Lee Array for
Microwave Background Anisotropy (AMiBA), an interferometric array designed to
measure the Sunyaev-Zel'dovich effect and the anisotropy of the Cosmic
Microwave Background (CMB). We perform several statistical tests on data from
pointed galaxy cluster observations taken in 2007 and noise data from long-term
blank sky observations and measurements with the feeds covered by the
absorbers. We apply power spectrum analysis, cross power spectrum analysis
among different outputs with different time lags in our analog correlator, and
sample variance law tests to noise data. We find that (1) there is no time
variation of electronic offsets on the time scale of our two-patch observations
(~10 minutes); (2) noise is correlated by less than 10% between different lags;
and (3) the variance of noise scales with the inverse of time. To test the
Gaussianity of the data, we apply Kolmogorov-Smirnov (K-S) tests to cluster
data, and find that a 5% significance level efficiently detects data sets with
known hardware problems without rejecting an excess of acceptable data. We also
calculate third- and fourth-order moments and cumulants for the noise residual
visibilities and find that about 95% of our data are within the 99% confidence
regions of Gaussianity.Comment: 15 pages, 5 figures, accepted for publication in Ap
Anthrax Toxins Induce Shock in Rats by Depressed Cardiac Ventricular Function
Anthrax infections are frequently associated with severe and often irreversible hypotensive shock. The isolated toxic proteins of Bacillus anthracis produce a non-cytokine-mediated hypotension in rats by unknown mechanisms. These observations suggest the anthrax toxins have direct cardiovascular effects. Here, we characterize these effects. As a first step, we administered systemically anthrax lethal toxin (LeTx) and edema toxin (EdTx) to cohorts of three to twelve rats at different doses and determined the time of onset, degree of hypotension and mortality. We measured serum concentrations of the protective antigen (PA) toxin component at various time points after infusion. Peak serum levels of PA were in the µg/mL range with half-lives of 10–20 minutes. With doses that produced hypotension with delayed lethality, we then gave bolus intravenous infusions of toxins to groups of four to six instrumented rats and continuously monitored blood pressure by telemetry. Finally, the same doses used in the telemetry experiments were given to additional groups of four rats, and echocardiography was performed pretreatment and one, two, three and twenty-four hours post-treatment. LeTx and EdTx each produced hypotension. We observed a doubling of the velocity of propagation and 20% increases in left ventricular diastolic and systolic areas in LeTx-treated rats, but not in EdTx-treated rats. EdTx-but not LeTx-treated rats showed a significant increase in heart rate. These results indicate that LeTx reduced left ventricular systolic function and EdTx reduced preload. Uptake of toxins occurs readily into tissues with biological effects occurring within minutes to hours of serum toxin concentrations in the µg/mL range. LeTx and EdTx yield an irreversible shock with subsequent death. These findings should provide a basis for the rational design of drug interventions to reduce the dismal prognosis of systemic anthrax infections
AMiBA: System Performance
The Y.T. Lee Array for Microwave Background Anisotropy (AMiBA) started
scientific operation in early 2007. This work describes the optimization of the
system performance for the measurements of the Sunyaev-Zel'dovich effect for
six massive galaxy clusters at redshifts . We achieved a point
source sensitivity of mJy with the seven 0.6m dishes in 1 hour of
on-source integration in 2-patch differencing observations. We measured and
compensated for the delays between the antennas of our platform-mounted
interferometer. Beam switching was used to cancel instrumental instabilities
and ground pick up. Total power and phase stability were good on time scales of
hours, and the system was shown to integrate down on equivalent timescales of
300 hours per baseline/correlation, or about 10 hours for the entire array.
While the broadband correlator leads to good sensitivity, the small number of
lags in the correlator resulted in poorly measured bandpass response. We
corrected for this by using external calibrators (Jupiter and Saturn). Using
Jupiter as the flux standard, we measured the disk brightness temperature of
Saturn to be K.Comment: 9 pages, 7 figures, 1 table, accepted for publication in Ap
Is quality of colorectal cancer care good enough? Core measures development and its application for comparing hospitals in Taiwan
<p>Abstract</p> <p>Background</p> <p>Although performance measurement for assessing care quality is an emerging area, a system for measuring the quality of cancer care at the hospital level has not been well developed. The purpose of this study was to develop organization-based core measures for colorectal cancer patient care and apply these measures to compare hospital performance.</p> <p>Methods</p> <p>The development of core measures for colorectal cancer has undergone three stages including a modified Delphi method. The study sample originated from 2004 data in the Taiwan Cancer Database, a national cancer data registry. Eighteen hospitals and 5585 newly diagnosed colorectal cancer patients were enrolled in this study. We used indicator-based and case-based approaches to examine adherences simultaneously.</p> <p>Results</p> <p>The final core measure set included seventeen indicators (1 pre-treatment, 11 treatment-related and 5 monitoring-related). There were data available for ten indicators. Indicator-based adherence possesses more meaningful application than case-based adherence for hospital comparisons. Mean adherence was 85.8% (79.8% to 91%) for indicator-based and 82.8% (77.6% to 88.9%) for case-based approaches. Hospitals performed well (>90%) for five out of eleven indicators. Still, the performance across hospitals varied for many indicators. The best and poorest system performance was reflected in indicators T5-negative surgical margin (99.3%, 97.2% - 100.0%) and T7-lymph nodes harvest more than twelve(62.7%, 27.6% - 92.2%), both of which related to surgical specimens.</p> <p>Conclusions</p> <p>In this nationwide study, quality of colorectal cancer care still shows room for improvement. These preliminary results indicate that core measures for cancer can be developed systematically and applied for internal quality improvement.</p
- …